Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Lawrence

Showing results (151-160 of 159) with videos related to

Pageof 16
Sort By:
You have reached the last page of results.This site can display upto 159 results.
International Journal of Cancer|January 29, 2015
Genomic aberrations in cervical adenocarcinomas in Hong Kong Chinese womenTony K H Chung, Paul Van Hummelen, Paul K S Chan, et al.
Nature Medicine|May 20, 2014
Whole-exome sequencing and clinical interpretation of formalin-fixed, paraffin-embedded tumor samples to guide precision cancer medicineEliezer M Van Allen, Nikhil Wagle, Petar Stojanov, et al.
Nature|March 27, 2025
Oxidation of retromer complex controls mitochondrial translationJunbing Zhang, Md Yousuf Ali, Harrison Byron Chong, et al.
Journal of Medicinal Chemistry|October 6, 2021
Screening Hit to Clinical Candidate: Discovery of BMS-963272, a Potent, Selective MGAT2 Inhibitor for the Treatment of Metabolic DisordersHuji Turdi, Hannguang Chao, Jon J Hangeland, et al.
Biorxiv : the Preprint Server for Biology|March 22, 2023
Identification of chemotherapy targets reveals a nucleus-to-mitochondria ROS sensing pathwayJunbing Zhang, Claire M Simpson, Jacqueline Berner, et al.
Journal of Medicinal Chemistry|September 25, 2025
Discovery of Potent and Selective Reversible Ubiquitin-Like Modifier Activating Enzyme 5 Inhibitors Targeting the UFMylation PathwayJames J Mignone, Elizabeth A Jurica, Deepa Rajasekaran, et al.
Journal of Medicinal Chemistry|November 3, 2015
Triphenylethanamine Derivatives as Cholesteryl Ester Transfer Protein Inhibitors: Discovery of N-[(1R)-1-(3-Cyclopropoxy-4-fluorophenyl)-1-[3-fluoro-5-(1,1,2,2-tetrafluoroethoxy)phenyl]-2-phenylethyl]-4-fluoro-3-(trifluoromethyl)benzamide (BMS-795311)Jennifer X Qiao, Tammy C Wang, Leonard P Adam, et al.
The Journal of Clinical Investigation|December 22, 2012
Prognostically relevant gene signatures of high-grade serous ovarian carcinomaRoel G W Verhaak, Pablo Tamayo, Ji-Yeon Yang, et al.
Cell|May 16, 2023
Systematic identification of anticancer drug targets reveals a nucleus-to-mitochondria ROS-sensing pathwayJunbing Zhang, Claire M Simpson, Jacqueline Berner, et al.
Pageof 16

Showing results (151-160 of 159) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 159 results.
International Journal of Cancer|January 29, 2015
Genomic aberrations in cervical adenocarcinomas in Hong Kong Chinese womenTony K H Chung, Paul Van Hummelen, Paul K S Chan, et al.
Nature Medicine|May 20, 2014
Whole-exome sequencing and clinical interpretation of formalin-fixed, paraffin-embedded tumor samples to guide precision cancer medicineEliezer M Van Allen, Nikhil Wagle, Petar Stojanov, et al.
Nature|March 27, 2025
Oxidation of retromer complex controls mitochondrial translationJunbing Zhang, Md Yousuf Ali, Harrison Byron Chong, et al.
Journal of Medicinal Chemistry|October 6, 2021
Screening Hit to Clinical Candidate: Discovery of BMS-963272, a Potent, Selective MGAT2 Inhibitor for the Treatment of Metabolic DisordersHuji Turdi, Hannguang Chao, Jon J Hangeland, et al.
Biorxiv : the Preprint Server for Biology|March 22, 2023
Identification of chemotherapy targets reveals a nucleus-to-mitochondria ROS sensing pathwayJunbing Zhang, Claire M Simpson, Jacqueline Berner, et al.
Journal of Medicinal Chemistry|September 25, 2025
Discovery of Potent and Selective Reversible Ubiquitin-Like Modifier Activating Enzyme 5 Inhibitors Targeting the UFMylation PathwayJames J Mignone, Elizabeth A Jurica, Deepa Rajasekaran, et al.
Journal of Medicinal Chemistry|November 3, 2015
Triphenylethanamine Derivatives as Cholesteryl Ester Transfer Protein Inhibitors: Discovery of N-[(1R)-1-(3-Cyclopropoxy-4-fluorophenyl)-1-[3-fluoro-5-(1,1,2,2-tetrafluoroethoxy)phenyl]-2-phenylethyl]-4-fluoro-3-(trifluoromethyl)benzamide (BMS-795311)Jennifer X Qiao, Tammy C Wang, Leonard P Adam, et al.
The Journal of Clinical Investigation|December 22, 2012
Prognostically relevant gene signatures of high-grade serous ovarian carcinomaRoel G W Verhaak, Pablo Tamayo, Ji-Yeon Yang, et al.
Cell|May 16, 2023
Systematic identification of anticancer drug targets reveals a nucleus-to-mitochondria ROS-sensing pathwayJunbing Zhang, Claire M Simpson, Jacqueline Berner, et al.
Pageof 16